Written by Abhishek Pathak
Published on Issue 1 Vol 1, 2021
The COVID‑19 outbreak has been a scourge for cancer patients. The absence of knowledge and ignorance in addressing cancer patients throughout this epidemic has deteriorated their illnesses. Gathering information about patients undergoing immunotherapy during the COVID-19 pandemic was the study's goal. The information gathered covered the diagnosis, some research, and the effects of the immunotherapy medications as well as their adverse effects. To examine the actual situation, we looked at 1
Read More
Written by Karpal Singh Sohal
Published on Issue 1 Vol 1, 2021
Low-grade odontogenic epithelial neoplasms, known as ameloblastomas, account for approximately 10% of odontogenic tumors and 1% of all oral malignancies. In rare cases, these tumors may spread to distant locations; if this occurs, they are called metastatic ameloblastomas. This article describes a case of an unusual type of maxillary ameloblastoma with lung metastasis and the challenges of managing it in resource-limited settings. In 2018, a 24-year-old African man presented with a significant s
Read More
Written by Rosa Coppola
Published on Issue 1 Vol 1, 2021
Targeted therapy has emerged as one of the most significant developments in cancer treatment in recent years. Patients with advanced, recurring, or metastatic cancer are treated with agents that target the epidermal growth factor receptor (EGFR). One of the most prevalent adverse reactions of EGFR inhibitors is skin damage. We report on a 70-year-old male patient with metastatic colorectal cancer who experienced an intertrigo-like eruption while receiving topical corticosteroid treatment as part
Read More
Written by Havva Yesil Cinkir
Published on Issue 1 Vol 1, 2021
In advanced non-small cell lung cancer (NSCLC), factors such as susceptibility to epidermal growth factor receptor tyrosine kinase inhibitors with pathological subtype of adenocarcinoma, smoking history, and female gender are predictive. However, we need novel predictive markers as well as driver mutations for improved therapy choices. The present study aimed to investigate the prognostic significance of sarcopenia in lung adenocancer patients treated with erlotinib. Skeletal muscle index (SMI)
Read More
Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.
Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.
